• Beiersdorf H1 2026 sales fell 3.5% organically to EUR 4.95 billion, with Consumer down 4% organically to EUR 4.11 billion.
• EBIT excluding special factors slipped to EUR 768 million, with the margin easing 0.6 percentage point to 15.5%.
• Net profit edged down to EUR 558 million, while EPS rose to EUR 2.52.
• NIVEA sales dropped 6.8% organically to EUR 2.7 billion on weaker shipments and a late European sun season, while Derma climbed 7.8% organically to EUR 837 million.
• Guidance cut for 2026 to a low-single-digit organic sales decline, with EBIT margin excluding special factors seen at least 11.8% as NIVEA turnaround spending rises.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Beiersdorf AG published the original content used to generate this news brief on August 03, 2026, and is solely responsible for the information contained therein.